<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Ephedra.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:32:41 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2085008">
<meta name="Category" content="Herb">
<meta name="Article" content="Ephedra">
<title>Efedra-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Efedra</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Ephedra.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Foster S. <em>Herbs for Your Health.</em> Loveland, CO: Interweave Press,
1996, 37&#8211;8.</li>

<li class="Ref">Tyler, VE. <em>The Honest Herbal,</em> 3d ed. Binghamton, NY: Pharmaceutical
Products Press, 1993, 119&#8211;21.</li>

<li class="Ref">Leung AY, Foster S. <em>Encyclopedia of Common Natural Ingredients Used in
Food, Drugs, and Cosmetics,</em> 2d ed. New York: John Wiley &amp; Sons, 1996,
227&#8211;9.</li>

<li class="Ref">Institute of Medicine. Dietary Reference Intakes: a risk assessment model for
establishing upper intake levels for nutrients. Washington, DC: National Academy Press,
1998.</li>

<li class="Ref">Cantox Health Sciences International. Safety assessment and determination of a
tolerable upper limit for ephedra. December 19, 2000.
www.crnusa.org/CRNCantoxreportindex.html.</li>

<li class="Ref">Foster S. <em>Herbs for Your Health.</em> Loveland, CO: Interweave Press,
1996, 37&#8211;8.</li>

<li class="Ref">Blumenthal M, Busse WR, Goldberg A, et al. (eds). <em>The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines.</em> Boston, MA: Integrative Medicine
Communications, 1998, 125&#8211;6.</li>

<li class="Ref">White LM, Gardner SF, Gurley BJ, et al. Pharmacokinetics and cardiovascular
effects of ma-huang <em>(Ephedra sinica)</em> in normotensive adults. <em>J Clin
Pharmacol</em> 1997;37:116&#8211;21.</li>

<li class="Ref">Blumenthal M, Busse WR, Goldberg A, et al. (eds). <em>The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines.</em> Boston, MA: Integrative Medicine
Communications, 1998, 125&#8211;6.</li>

<li class="Ref">Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: Ephedrine
nephrolithiasis. <em>Am J Kidney Dis</em> 1998;32:153&#8211;9.</li>

<li class="Ref">Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system
events associated with dietary supplements containing ephedra alkaloids. <em>New Engl J
Med</em> 2000;343:1833&#8211;8.</li>

<li class="Ref">Blumenthal M, Busse WR, Goldberg A, et al. (eds). <em>The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines.</em> Boston, MA: Integrative Medicine
Communications, 1998, 125&#8211;6.</li>

<li class="Ref">Cantox Health Sciences International. Safety assessment and determination of a
tolerable upper limit for ephedra. December 19, 2000.
www.crnusa.org/CRNCantoxreportindex.html</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Ephedra.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:32:41 GMT -->
</html>

